Skip to main content

Targeted and controlled delivery systems of bioactive molecules

RYC2018-025617-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDADE DA CORUÑA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Chondrogenic Differentiation of Human Mesenchymal Stem Cells via SOX9 Delivery in Cationic Niosomes

  • Carballo-Pedrares, Natalia
  • Sanjurjo-Rodríguez, Clara
  • Señarís, José
  • Díaz-Prado, Silvia
  • Rey-Rico, Ana
[Abstract] Gene transfer to mesenchymal stem cells constitutes a powerful approach to promote their differentiation into the appropriate cartilage phenotype. Although viral vectors represent gold standard vehicles, because of their high efficiency, their use is precluded by important concerns including an elevated immunogenicity and the possibility of insertional mutagenesis. Therefore, the development of new and efficient non-viral vectors is under active investigation. In the present study, we developed new non-viral carriers based on niosomes to promote the effective chondrogenesis of human MSCs. Two different niosome formulations were prepared by varying their composition on non-ionic surfactant, polysorbate 80 solely (P80), or combined with poloxamer 407 (P80PX). The best niosome formulation was proven to transfer a plasmid, encoding for the potent chondrogenic transcription factor SOX9 in hMSC aggregate cultures. Transfection of hMSC aggregates via nioplexes resulted in an increased chondrogenic differentiation with reduced hypertrophy. These results highlight the potential of niosome formulations for gene therapy approaches focused on cartilage repair., The work was supported by MICINN [RTI2018-099389-A-100, RYC2018-025617-I] and Xunta de Galicia [ED431F2021/10]., Xunta de Galicia; ED431F2021/10
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Niosomes-Based Gene Delivery Systems for Effective Transfection of Human Mesenchymal Stem Cells

  • Carballo-Pedrares, Natalia
  • Kattar, Axel
  • Concheiro, Ángel
  • Álvarez-Lorenzo, Carmen
  • Rey-Rico, Ana
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract] Gene transfer to mesenchymal stem cells (MSCs) has arisen as a powerful approach to increase the therapeutic potential of this effective cell population. Over recent years, niosomes have emerged as self-assembled carriers with promising performance for gene delivery. The aim of our work was to develop effective niosomes-based DNA delivery platforms for targeting MSCs. Niosomes based on 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA; 0, 7 or 15%) as cationic lipid, cholesterol as helper lipid, and polysorbate 60 as non-ionic surfactant, were prepared using a reverse phase evaporation technique. Niosomes dispersions (filtered or not) and their corresponding nioplexes with a lacZ plasmid were characterized in terms of size, charge, protection, and complexation abilities. DOTMA concentration had a large influence on the physicochemical properties of resulting nioplexes. Transfection efficiency and cytotoxic profiles were assessed in two immortalized cell lines of MSCs. Niosomes formulated with 15% DOTMA provided the highest values of β-galactosidase activity, being similar to those achieved with Lipofectamine®, but showed less cytotoxicity. Filtration of niosomes dispersions before adding to the cells resulted in a loss of their biological activities. Storage of niosomes formulations (for 30 days at room temperature) caused minor modification of their physicochemical properties but also attenuated the transfection capability of the nioplexes. Differently, addition of the lysosomotropic agent sucrose into the culture medium during transfection or to the formulation itself improved the transfection performance of non-filtered niosomes. Indeed, steam heat-sterilized niosomes prepared in sucrose medium demonstrated transfection capability., The work was supported by MICINN [RTI2018-099389-A-100; PID2020-113881RB-I00], Agencia Estatal de Investigación (AEI) Spain, Xunta de Galicia [ED431C 2020/17], and FEDER. A. Rey-Rico acknowledges MICINN for the Ramón y Cajal Fellowship [RYC2018-025617-I] and Universidade da Coruña/CISUG for the funding for open access charge. This project was also funded by the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions grant agreement N° 813440 (ORBITAL–Ocular Research by Integrated Training And Learning), Xunta de Galicia; ED431C 2020/17
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Non-viral Gene Delivery to Human Mesenchymal Stem Cells: A Practical Guide Towards Cell Engineering

  • López-Seijas, Junquera
  • Rey-Rico, Ana
  • Carballo-Pedrares, Natalia
  • Ponti, Federica
  • Miranda-Balbuena, Diego
  • Bono, Nina
  • Candiani, Gabriele
Review, [Abstract] In recent decades, human mesenchymal stem cells (hMSCs) have gained momentum in the field of cell therapy for treating cartilage and bone injuries. Despite the tri-lineage multipotency, proliferative properties, and potent immunomodulatory effects of hMSCs, their clinical potential is hindered by donor variations, limiting their use in medical settings. To address this challenge, gene delivery technologies have emerged as a promising approach to modulate the phenotype and commitment of hMSCs towards specific cell lineages, thereby enhancing osteochondral repair strategies. This review provides a comprehensive overview of current non-viral gene delivery approaches used to engineer MSCs, highlighting key factors such as the choice of nucleic acid or delivery vector, transfection strategies, and experimental parameters. Additionally, it outlines various protocols and methods for qualitative and quantitative evaluation of their therapeutic potential as a delivery system in osteochondral regenerative applications. In summary, this technical review offers a practical guide for optimizing non-viral systems in osteochondral regenerative approaches., We thank Biobanco de A Coruña from SERGAS for providing biological simples. ARR acknowledges MICINN [PID2021-128461OB-100; RYC2018-025617-I;] and Xunta de Galicia [ED431F2021/10] for the funding. JLS acknowledges MICINN [FPU20/06176] for her pre-doctoral fellowship grant and NCP acknowledges Inditex-UDC 2021grant for her pre-doctoral stay funding, Xunta de Galicia; ED431F2021/10
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Development of New Non-viral Systems for Genetic Modification of Senescent Cells

  • López-Seijas, Junquera
  • Miranda-Balbuena, Diego
  • Iglesias-Fente, Alba
  • Sacristán-Santos, Marta
  • Carballo-Pedrares, Natalia
  • Arufe, M.C.
  • Rey-Rico, Ana
  • Fafián-Labora, J.A.
[Abstract] Senescence is a process characterized by a prolonged irreversible cell-cycle arrest. The accumulation of senescent cells in tissues is related to aging and to the development of age-related diseases. Recently, gene therapy has emerged as a powerful tool for treating age-associated diseases by the transference of specific genes into the target cell population. However, the high sensitivity of senescent cells significantly precludes their genetic modification via classical viral and non-viral systems. Niosomes are self-assembled non-viral nanocarriers that exhibit important advantages due to their elevated cytocompatibility, versatility, and cost-efficiency, arising as a new alternative for genetic modification of senescent cells. In this work, we explore for the first time the use of niosomes for genetic modification of senescent umbilical cord-derived mesenchymal stem cells. We report that niosome composition greatly affected transfection efficiency; those formulations prepared in medium with sucrose and containing cholesterol as helper lipid being the most suitable to transfect senescent cells. Moreover, resulting niosome formulations exhibited a superior transfection efficiency with a markedly less cytotoxicity than the commercial reagent Lipofectamine. These findings highlight the potentiality of niosomes as effective vectors for genetic modification of senescent cells, providing new tools for the prevention and/or treatment of age-related diseases., The work was supported by MICINN (RTI2018-099389-A-100; RYC2018-025617-I; RYC2021-032567-I), Xunta de Galicia (ED431F2021/10; ED481D-2021-020), and Spanish National Health Institute Carlos III (PI20/00497). J.L.-S. acknowledges MICINN (FPU20/06176) for her pre-doctoral fellowship grant. J.F.-L. also gives thanks to the InTalent program from UDC-Inditex for the research grant., Xunta de Galicia; ED431F2021/10, Xunta de Galicia; ED481D-2021-020
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Scaffold-Mediated Gene Delivery for Osteochondral Repair

  • Madry, Henning
  • Venkatesan, Jagadeesh Kumar
  • Carballo-Pedrares, Natalia
  • Rey-Rico, Ana
  • Cucchiarini, Magali
[Abstract] Osteochondral defects involve both the articular cartilage and the underlying subchondral bone. If left untreated, they may lead to osteoarthritis. Advanced biomaterial-guided delivery of gene vectors has recently emerged as an attractive therapeutic concept for osteochondral repair. The goal of this review is to provide an overview of the variety of biomaterials employed as nonviral or viral gene carriers for osteochondral repair approaches both in vitro and in vivo, including hydrogels, solid scaffolds, and hybrid materials. The data show that a site-specific delivery of therapeutic gene vectors in the context of acellular or cellular strategies allows for a spatial and temporal control of osteochondral neotissue composition in vitro. In vivo, implantation of acellular hydrogels loaded with nonviral or viral vectors has been reported to significantly improve osteochondral repair in translational defect models. These advances support the concept of scaffold-mediated gene delivery for osteochondral repair., This research was funded by the Deutsche Forschungsgemeinschaft (DFG VE 1099/1-1 to JKV, HM, and MC), the Ministerio de Ciencia e Innovación (RTI2018-099389-A-100 to A.R.-R.), and the Ministerio de Ciencia e Innovación for a Ramón y Cajal Fellowship (RYC2018-025617-I to A.R.-R.)., Deutsche Forschungsgemeinschaft; DFG VE 1099/1-1
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Gene-Activated Hyaluronic Acid-Based Cryogels for Cartilage Tissue Engineering

  • López-Seijas, Junquera
  • Rey-Rico, Ana
  • Carballo-Pedrares, Natalia
  • Miranda-Balbuena, Diego
  • Lamas Criado, Ibán
  • Yáñez, Julián
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract] Articular cartilage injuries are very frequent lesions that if left untreated may degenerate into osteoarthritis. Gene transfer to mesenchymal stem cells (MSCs) provides a powerful approach to treat these lesions by promoting their chondrogenic differentiation into the appropriate cartilage phenotype. Non-viral vectors constitute the safest gene transfer tools, as they avoid important concerns of viral systems including immunogenicity and insertional mutagenesis. However, non-viral gene transfer usually led to lower transfection efficiencies when compared with their viral counterparts. Biomaterial-guided gene delivery has emerged as a promising alternative to increase non-viral gene transfer efficiency by achieving sustained delivery of the candidate gene into cellular microenvironment. In the present study, we designed hyaluronic acid-based gene-activated cryogels (HACGs) encapsulating a novel formulation of non-viral vectors based on niosomes (P80PX) to promote MSCs in situ transfection. The developed HACG P80PX systems showed suitable physicochemical properties to promote MSCs in situ transfection with very low cytotoxicity. Incorporation of a plasmid encoding for the transcription factor SOX9 (psox9) into HACG P80PX systems led to an effective MSCs chondrogenic differentiation with reduced expression of fibrocartilage and hypertrophic markers. The capacity of the developed systems to restore cartilage extracellular matrix was further confirmed in an ex vivo model of chondral defect., Funding: The work was supported by MICINN [RTI2018-099389-A-100, RYC2018-025617-I], Xunta de Galicia [ED431F2021/10] and Deputación da Coruña [BINV-CS/2022, 2022000021445]. Acknowledgements: We would like to acknowledge Prof. M. Cucchiarini for providing pACP-hsox9 (psox9, bp 6,915). We also thank Biobanco de A Coruña from SERGAS for providing biological samples, BASF (Ludwigshafen, Germany) for supplying the poloxamer 407 and Universidade da Coruña/CISUG for the funding for open access charge., Xunta de Galicia; ED431F2021/10, Deputación da Coruña; BINV-CS/2022, 2022000021445
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Targeted Chondrogenic Differentiation of Human MSCs Using Niosomes for SOX9 Gene Delivery: Comparison of Minicircle and Conventional Plasmids

  • López-Seijas, Junquera
  • Iglesias-Fente, Alba
  • Ramil-Bouzas, Alba
  • Paniagua Barro, Sara
  • Fafián-Labora, J. A.
  • Rey-Rico, Ana
Supplementary Material: 1. Table S1. Polydispersity index (PDI) of niosomes and nioplexes. – 2. Figure S1. Characterization of hMSC – 3. Figure 1: Original full-length uncropped., [Abstract] Background Niosomes represent a promising non-viral gene delivery system, offering an alternative to viral vectors for the genetic modification of hard-to-transfect cells, such as mesenchymal stem cells (MSCs), which are pivotal in regenerative medicine. Specifically, SOX9 gene transfer is a valuable strategy for cartilage tissue repair, as it promotes chondrocyte differentiation while repressing hypertrophic and osteogenic markers. In this study, we investigated the potential of niosomes to deliver SOX9, using both parental and minicircle plasmids, to induce chondrogenic differentiation in primary bone marrow-derived human MSCs (hMSCs). Methods Niosomes were synthesised using the thin-film hydration method and complexed with either parental or minicircle SOX9 plasmids to form nioplexes. Physicochemical properties of niosomes and nioplexes were studied in terms of size, zeta potential, complexation, and protection capacity. Primary hMSCs were transfected in a 2D monolayer and 3D aggregate cultures using Lipofectamine as a positive control of transfection. Chondrogenic differentiation was assessed by gene expression (SOX9, ACAN, COLII, COLI, COLX), histological and immunohistochemical staining (Toluidine blue, haematoxylin & eosin and SOX9, COLII, COLI, COLX, respectively), and biochemical (proteoglycans, DNA and protein contents) analyses of main cartilage markers. Results SOX9 delivery via DP20CQ niosome systems significantly enhanced the expression of key chondrogenic markers (SOX9, ACAN, and COLII) and increased production of a characteristic hyaline-like cartilage matrix. In contrast, Lipofectamine-based complexes induced hypertrophic and fibrocartilaginous phenotypes, evidenced by increased expression of COLX and COLI. Quantification of proteoglycan production, along with proteins and DNA content, supported these findings. Both plasmid types promoted comparable chondrogenic outcomes, but parental plasmids yielded more consistent results than minicircles. Conclusions Delivery of SOX9 plasmids via niosomes promotes enhanced chondrogenic differentiation of primary hMSCs in a 3D aggregate culture system, leading to the formation of hyaline-like cartilage tissue. This non-viral strategy represents a promising gene delivery platform for cartilage reparative therapies., This work was supported by MICINN [RYC2018-025617-I and CNS2024-154660] and Xunta de Galicia [ED431F2021/10]. JLS and ARB acknowledge MICINN [FPU20/06176; PRE2022-104070, respectively] and AIF thanks Xunta de Galicia (ED481A 2022/041) for their pre-doctoral fellowship grants., Xunta de Galicia; ED431F2021/10, Xunta de Galicia; ED481A 2022/041
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Exploiting Niosomes as Efficient Non-Viral Vectors for Enhanced Gene Transfer to Human Mesenchymal Stem Cells

  • López-Seijas, Junquera
  • Iglesias-Fente, Alba
  • Miranda-Balbuena, Diego
  • Rey-Rico, Ana
[Abstract] Gene therapy of mesenchymal stem cells (MSCs) represents a powerful tool to enhance their therapeutic potential for regenerative medicine approaches. Among current non-viral vectors used for MSCs transfection, niosomes are preferred over classical liposomes due to their reduced cytotoxicity. However, the use of niosomes is hindered by the lack of optimization in its composition, precluding their efficiency, especially when using in hard-to-transfect cells as MSCs. To develop effective niosome formulations for gene delivery to human MSCs, this study explores, for the first time, a broad range of compositions and mole ratios and their impact on transfection efficiency. Formulations containing the cationic lipid DOTMA, the non-ionic surfactants polysorbate 20 or polysorbate 80, and the helper lipids cholesterol (DP80CH) or chloroquine (DP20CQ), at a 1:2:2 M ratio and DOTMA/DNA ratio of 5/1, achieved the highest lacZ and GFP reporter transgene expressions in MSCs. Endocytosis pathway analysis revealed that niosome composition strongly influenced cellular uptake, with DP80CH niosomes being internalized via macropinocytosis and caveolae-dependent endocytosis, while DP20CQ niosomes primarily utilized the latter mechanism. Physicochemical characterization confirmed their suitability for gene delivery applications. These findings demonstrate the potential of niosomes as effective vectors for MSCs genetic modification, offering new strategies for the prevention and treatment of various diseases., This work was supported by MICINN [RYC2018-025617-I] and Xunta de Galicia [ED431F2021/10]. JLS acknowledges MICINN [FPU20/06176] and AIF acknowledges Xunta de Galicia (ED481A 2022/041) for their pre-doctoral fellowship grant., Xunta de Galicia; ED431F2021/10, Xunta de Galicia; ED481A 2022/041
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Poly(O-Propargyl-N-Amino Carbamate), a Reactive Polymer to Underpin Biomedical Applications of Poly(Acetylene)S

  • Leigh, Thomas
  • Bellio, Greta
  • Crisan, Daniel N.
  • Deb, Amit
  • Ramil-Bouzas, Alba
  • Romanyuk, Andrey
  • Torreiro-León, Iván
  • Rey-Rico, Ana
  • Fernández-Trillo, Paco
[Abstract] Synthetic polymers are widely used in biomedical applications, yet most lack defined secondary structures common in nature,such as helices or β-sheets. In particular, dynamic helical polymers such as poly(acetylene)s have been rarely explored in thisfield. Here, we report the preparation of a new reactive poly(acetylene), poly(O-propargyl-N-amino carbamate) (P1), as a platformfor the preparation of functional poly(acetylene)s in water. P1 was prepared from readily available starting materials throughRh-catalyzed polymerization and acid-mediated deprotection. 1 H-NMR indicated that the formed polymer had a high content ofcis double bonds, while UV–vis and DSC suggested a predominant cis-cisoid conformation. This conformation was also observedvia CD for chiral derivatives of Boc-protected P1, while a partially deprotected chiral derivative of P1 could be adopting multipleconformations in solution, including cis-transoid and cis-cisoid conformations. P1 was functionalized under aqueous conditionswith a small set of aldehydes, including cationic, aliphatic, and aromatic derivatives, as well as a small set of carbohydrates. Finally,we demonstrate that P1, and a guanidinium derivative P1-mod-4, were well tolerated by cells, highlighting the potential of thispolymer to underpin the development of biomedical applications of poly(acetylene)s, The work is supported by the University of Birmingham (John Evans fellowship to P.F.-T., PhD studentship to D.C.), the Spanish Ministerio de Educación, Cultura y Deporte (Beatriz Galindo Award to P.F.-T., BG20/00213), the Engineering and Physical Sciences Research Council and the Centre for Doctoral Training in Physical Sciences for Health (PhD studentship to T.L., EP/L016346/1), the Leverhulme Trust (PhD studentship to A.D. under grant RPG-2019-382), the Ministerio de Ciencia, Innovación y Universidades (Ramon y Cajal Fellowship to A.R.-R., RYC2018-025617-I, and pre-doctoral fellowship toA.R.-B., PRE2022-104070), the European Union’s Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Grant Agreement No. 795082 toA.R.), the La Caixa Foundation (CI22-00167) and Xunta de Galicia (ED431F 2021/10 and ED431B 2023/60). This work is part of the project PID2021-128461OB-I00, funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, Xunta de Galicia; ED431F 2021/10, Xunta de Galicia; ED431B 2023/60, Reino Unido. Engineering and Physical Sciences Research Council, UK; EP/L016346/1, Reino Unido. The Leverhulme Trust; RPG-2019-382, Fundación La Caixa; CI22-00167